NANOTECHNOLOGY BASED DETECTION AND THERAPY OF OVARIAN CANCER

Abstract

Ovarian carcinoma is the leading reason behind death from gynaecologic malignancies, which could be a direct outcome
of missing its diagnosis at an early stage. Nanotechnology has great promise in addressing existing problems to boost the
diagnosis and therapy of Ovarian Cancer. Nanocarriers are multifunctional as several varieties of molecules are
often loaded onto them through physical adsorption or chemical conjugations including drugs, imaging agents, targeting
moieties like ligands or Antibodies. Present research for earlier detection of Ovarian Cancer focuses on identifying
Ovarian Cancer biomarkers through developing a profile of aberrantly expressed molecules and by enhancing imaging
techniques. This early detection will ultimately lead to a stronger prognosis and an increased survival rate. Also,
Nanotechnology can improve screening for ovarian Cancer by fabricating lab-on-a-chip microfluidic devices for immunoscreening. Overall, the incorporation of nanotechnology into existing detection methods of Ovarian cancer demonstrates
great promise in detecting the disease at an earlier stage. With the arrival of nanotechnology, it'll be possible to detect
the previously undetectable concentrations of Ovarian Cancer biomarkers and visualize Ovarian Cancer cells in realtime.